相关实验视频

Updated: Feb 1, 2026

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

乙核酸酶:在瘤微环境中的可能作用以及对乳腺癌瘤进展的影响

Thaís Cristino Rocha-Vieira¹, José Roberto Meyer-Fernandes²

¹Institute of Medical Biochemistry Leopoldo de Meis, Center for Health Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Biochimica et biophysica acta. General subjects

|January 30, 2026

概括

瘤微环境显示出更高的细胞外ATP,由CD39和CD73降解为腺. 这抑制免疫力,促进乳腺癌转移,表明ectonucleotidase活性作为治疗点.

科学领域:

生物化学生物化学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

与正常组织相比,瘤微环境 (TME) 的细胞外腺三酸盐 (ATP) 水平较高.
细胞外ATP通过CD39和ecto-5'-核酶 (CD73) 酶性转化为腺和酸盐 (Pi).
这种转化将TME从促炎状态转移到由腺积累驱动的抗炎状态.

研究的目的:

为了调查ectonucleotidases,特别是CD39和CD73在乳腺癌进展中的作用.
探索由这些酶产生的腺和细胞外Pi对瘤转移,血管生成和免疫抑制的影响.
评估ectonucleotidase活性作为乳腺癌治疗的潜在治疗标.

主要方法:

在瘤微环境中分析细胞外ATP,腺素和Pi度.
评估ECTONUCLEOTIDASE活性 (CD39/CD73) 和乳腺癌进展标志物之间的相关性.
研究腺和Pi对癌细胞迁移,入侵和血管生成的影响.体外和体内模型.
评估ectonucleotidases与化学抵抗和上皮细胞-介质细胞过渡 (EMT) 的关联.

主要成果:

与非瘤组织相比,瘤微环境中观察到细胞外ATP度升高.
CD39和CD73的合作作用导致腺和Pi的增加,促进一种抗炎性TME.
发现腺素可以诱导乳腺癌的迁移,转移和血管生成.
细胞外Pi通过增强转移能力,促进瘤的进展.
埃克托-5'-核代酶与免疫抑制,化学抵抗和表皮细胞-介质酶过渡的激活有关.

结论:

通过CD39/CD73通路的ECTONUCLEOTIDASE活性在促进乳腺癌进展和转移方面发挥着重要作用.
这些酶产生的腺和Pi有助于免疫逃避和治疗耐药性.
向ectonucleotidase活性是克服乳腺癌进展和转移的有希望的治疗策略.

关键词:

亚丁氨酸 (Adenosine) 是一种乳腺癌是什么? 乳腺癌是什么 CD39 CD39 是一个 CD73 CD73 CD73 CD73 CD73 CD73 CD73 CD73 CD73 CD73 CD73 乙核核酸酶是什么意思?瘤微环境是一个微环境.

更多相关视频

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics

Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics

Published on: December 1, 2023

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.